Recent Company News

• 04:29 PM ET Oct 23, 2025
  

  Galapagos to present In Vitro Data at ACR Convergence 2025 on GLPG3667 vs other TYK2 Inhibitors (€27.78, 0.00)

• 05:27 PM ET Oct 21, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:39 AM ET Oct 21, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:15 PM ET Oct 21, 2025
  

  Galapagos upgraded to outperform from market perform at Leerink Partners ($31.43, 0.00)

• 09:21 AM ET Oct 21, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:23 AM ET Oct 21, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:00 AM ET Oct 21, 2025
  

  Real estate, banks and insurance the best performers; chemicals, basic resources the big laggards:

• 04:23 AM ET Oct 21, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning